Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jens Ackerstaff is active.

Publication


Featured researches published by Jens Ackerstaff.


Journal of Medicinal Chemistry | 2017

Discovery of the Soluble Guanylate Cyclase Stimulator Vericiguat (BAY 1021189) for the Treatment of Chronic Heart Failure

Markus Follmann; Jens Ackerstaff; Gorden Redlich; Frank Wunder; Dieter Lang; Armin Kern; Peter Fey; Nils Griebenow; Eva-Maria Becker-Pelster; Axel Kretschmer; Volker Geiss; Volkhart Min-Jian Li; Alexander Straub; Joachim Mittendorf; Rolf Jautelat; Hartmut Schirok; Karl-Heinz Schlemmer; Klemens Lustig; Michael Gerisch; Andreas Knorr; Hanna Tinel; Thomas Mondritzki; Hubert Trübel; Peter Sandner; Johannes-Peter Stasch

The first-in-class soluble guanylate cyclase (sGC) stimulator riociguat was recently introduced as a novel treatment option for pulmonary hypertension. Despite its outstanding pharmacological profile, application of riociguat in other cardiovascular indications is limited by its short half-life, necessitating a three times daily dosing regimen. In our efforts to further optimize the compound class, we have uncovered interesting structure-activity relationships and were able to decrease oxidative metabolism significantly. These studies resulting in the discovery of once daily sGC stimulator vericiguat (compound 24, BAY 1021189), currently in phase 3 trials for chronic heart failure, are now reported.


Archive | 2011

Substituted 5-fluoro-1h-pyrazolopyridines and use thereof

Markus Follmann; Johannes-Peter Stasch; Gorden Redlich; Jens Ackerstaff; Nils Griebenow; Andreas Knorr; Eva-Maria Becker; Frank Wunder; Volkhart Min-Jian Li; Elke Hartmann; Joachim Mittendorf; Karl-Heinz Schlemmer; Rolf Jautelat; Donald Bierer


Archive | 2011

METHOD FOR THE PRODUCTION OF 5-FLUORO-1H-PYRAZOLO[3,4-B]PYRIDINE-3-CARBONITRILE

Markus Follmann; Jens Ackerstaff


Archive | 2016

SUBSTITUTED PHENYLALANINE DERIVATIVES

Ulrike Röhn; Manuel Ellermann; Julia Strassburger; Astrid Wendt; Susanne Röhrig; Robert Webster; Martina Victoria Schmidt; Adrian Tersteegen; Kristin Beyer; Martina Schäfer; Anja Buchmüller; Christoph Gerdes; Michael Sperzel; Steffen Sandmann; Stefan Heitmeier; Alexander Hillisch; Jens Ackerstaff; Carsten Terjung


Archive | 2013

BICYCLICALLY SUBSTITUTED URACILS AND THE USE THEREOF

Chantal Fürstner; Jens Ackerstaff; Alexander Straub; Heinrich Meier; Hanna Tinel; Katja Zimmermann; Adrian Tersteegen; Dimitry Zubov; Raimund Kast; Jens Schamberger; Martina Schäfer; Kirsten Börngen


Archive | 2016

SUBSTITUTED PHENYLALANINE DERIVATIVES AS MODULATORS OF FACTOR XIA

Ulrike Röhn; Manuel Ellermann; Julia Strassburger; Astrid Wendt; Susanne Röhrig; Robert Webster; Martina Victoria Schmidt; Adrian Tersteegen; Kristin Beyer; Martina Schäfer; Anja Buchmüller; Christoph Gerdes; Michael Sperzel; Steffen Sandmann; Stefan Heitmeier; Alexander Hillisch; Jens Ackerstaff; Carsten Terjung


Archive | 2012

Substituted imidazopyridines and the use thereof

Markus Follmann; Johannes-Peter Stasch; Gorden Redlich; Alexander Straub; Jens Ackerstaff; Nils Griebenow; Andreas Knorr; Frank Wunder; Volkhart Min-Jian Li


Archive | 2015

AMINO-SUBSTITUTED ISOTHIAZOLES

Lars Bärfacker; Stefan Prechtl; Gerhard Siemeister; Antje Margret Wengner; Jens Ackerstaff; Katrin Nowak-Reppel; Benjamin Bader; Philip Lienau; Detlef Stöckigt


Archive | 2011

Substituted methyl-pyrimidin-5-yl carbamates and use thereof

Jens Ackerstaff; Markus Follmann; Nils Griebenow; Rolf Jautelat; Andreas Knorr; Volkhart Min-Jian Li; Gorden Redlich; Hartmut Schirok; Johannes-Peter Stasch; Frank Wunder


Archive | 2011

Substituted oxazolidinones and oxazinanones and use thereof

Jens Ackerstaff; Markus Follmann; Nils Griebenow; Rolf Jautelat; Andreas Knorr; Volkhart Min-Jian Li; Gorden Redlich; Hartmut Schirok; Johannes-Peter Stasch; Frank Wunder

Collaboration


Dive into the Jens Ackerstaff's collaboration.

Top Co-Authors

Avatar

Gorden Redlich

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar

Markus Follmann

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Nils Griebenow

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar

Rolf Jautelat

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar

Adrian Tersteegen

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar

Min-Jian Li Volkhart

Bayer HealthCare Pharmaceuticals

View shared research outputs
Researchain Logo
Decentralizing Knowledge